Share

October 2015; 5 (5) Eye on Practice

How neurologists are paid

Part 3: Hospital support, Veterans Administration, and neurohospitalists

Peter D. Donofrio, Gregory L. Barkley, Bruce H. Cohen, David A. Evans, Gregory J. Esper, Bryan Soronson, Jeffrey R. Buchhalter, Amanda Becker
First published September 17, 2015, DOI: https://doi.org/10.1212/CPJ.0000000000000184
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
606

Share

This article has a correction. Please see:

Article Information

vol. 5 no. 5 412-418
DOI: 
https://doi.org/10.1212/CPJ.0000000000000184
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published September 17, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Peter D. Donofrio, MD,
    2. Gregory L. Barkley, MD,
    3. Bruce H. Cohen, MD,
    4. David A. Evans, MBA,
    5. Gregory J. Esper, MD, MBA,
    6. Bryan Soronson, MPA,
    7. Jeffrey R. Buchhalter, MD, PhD and
    8. Amanda Becker
  1. Peter D. Donofrio, MD,
    2. Scientific Advisory Boards:

    1. CSL Behring, Baxter, UCB CellTech

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Talecris Pharmaceuticals, honoraria from the AAN for speaking activities and serving on committees

    Editorial Boards:

    1. Muscle & Nerve, editorial board, 2008-2013

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. CSL Behring

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Gregory L. Barkley, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. honoraria from the AAN for speaking activities and serving on committees

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. I am paid a stipend by the American Academy of Neurology (AAN) for my time spent at the AMA- RBRVS Update Committee (AMA-RUC) as a representative of the AAN.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Currently an investigator on a NeuroPace device trial.

    Research Support, Government Entities:

    1. NINDS, NICHD U01 NS038455, PI: Meador, HFH site PI: Barkley

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Bruce H. Cohen, MD,
    4. Scientific Advisory Boards:

    1. DSMB-Stem Cell Transplantation for MNGIE (non-profit) Chairman-External Advisory Board of Clinical Protocols, Neurofibromatosis Consortium, Department of Defense

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. honoraria from the AAN for speaking activities and serving on committees

    Editorial Boards:

    1. Editorial Board for Pediatric Neurology Editorial Board for Mitochondrion

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Motive Medical Intelligence; content editor (formally known as New Mentor), commercial Stealth Biotherapeutics: Commercial Mitobridge: Commercial

    Speakers' Bureaus:

    1. Speakers Bureau: Transgenomic Labs (commercial) through December 31, 2010 Speakers Bureau: United Mitochondrial Disease Foundation (non-profit) Courtagen Labs

    Other activities:

    1. I am a consultant to Health and Human Services for the Division of Vaccine Injury Compensation Program.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Edison Pharmaceuticals, Raptor Pharmaceuticals, Stealth Biotherapeutics and Reata Pharma. I have received reimbursement for travel expenses related to scientific study management but have not received any financial incentive or money or research support or salary support. My hospital does have a contract with these companies for conducting research but I accept no specific salary support or accept money outside of this contract.

    Research Support, Government Entities:

    1. I am a consultant to Health and Human Services for the Vaccine Compensation Program and review cases and intend to provide testimony in the future. NIH

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. I am a consultant to Health and Human Services for the Division of Vaccine Injury Compensation Program; Government 2008-present Various Medical-Legal Cases; expert witness for defense, current

  4. David A. Evans, MBA,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Commercial, travel/honoraria, Merz Pharmaceuticals honoraria from the AAN for speaking activities and serving on committees

    Editorial Boards:

    1. MGMA Connection, Editorial review board, nonpaid 2011-2013

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Texas Neurology, Chief Executive Officer, 1996-present

    Consultancies:

    1. Commercial, Merz Pharmaceuticals, Allergan

    Speakers' Bureaus:

    1. American Academy of Neurology

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Gregory J. Esper, MD, MBA,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. honoraria from the AAN for speaking activities and serving on committees

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. receives compensation for Executive Education as an affiliate professor for HEC Paris School of Business

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. American Association of Medical Colleges

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Maglio, Christopher and Toale Law firm, expert witness, vaccine induced neurological diseases, 2010-2015 Oliver Maner LLC, expert witness, 2013-2015

  6. Bryan Soronson, MPA,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Society of Clinical Research Associates- travel and honoraria American Academy of Neurology- travel and honoraria Medical Group Management Assn- travel

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Raleigh Neurology PA Texas Neurology PA

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Jeffrey R. Buchhalter, MD, PhD and
    8. Scientific Advisory Boards:

    1. Observational Safety Monitoring Board- NIH, Benign Epilepsy of Childhood with Central Temporal Spikes Charlie Foundation Scientific Advisory Board IDIC 15 Scientific Advisory Board

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. AAN, webinar series,honoraria AAN, course director, honoraria AAN, Medical Economics & Management Committee Eisai Ltd, honorarium for webinar series, speaking, consulting Lundbeck, honorarium for speaking, consulting Upsher-Smith Labs, honorarium for consulting

    Editorial Boards:

    1. Clinical Neurology News, editorial advisory board, 2010-15

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Lundbeck Inc., Eisai Ltd. and Upsher-Smith

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Alberta Health Services- CMO Quality Improvement grant, principle investigator, 1 year

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Amanda Becker
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. honoraria from the AAN for speaking activities and serving on committees

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. American Academy of Neurology, Senior Director, Medical Economics & Quality, 13 years

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Vanderbilt University Medical Center (PDD), Nashville, TN; Henry Ford Hospital (GLB), Detroit, MI; Children's Hospital Medical Center of Akron (BHC), OH; Texas Neurology (DAE), Dallas; Emory University (GJE), Atlanta, GA; University of Maryland (BS), School of Medicine, Baltimore; University of Calgary (JRB), Alberta Children's Hospital, Canada; and American Academy of Neurology (AB), Minneapolis, MN.
  1. Correspondence to:
    peter.donofrio{at}vanderbilt.edu
View Full Text

Article usage

Article usage: September 2015 to April 2022

AbstractFullPdfSource
Sep 20159208Highwire
Oct 20152701536Highwire
Nov 2015163314Highwire
Dec 2015100110Highwire
Jan 20167400Highwire
Feb 201610665Highwire
Mar 20167518Highwire
Apr 20164915Highwire
May 20166704Highwire
Jun 20164630Highwire
Jul 20163623Highwire
Aug 20164200Highwire
Sep 20165009Highwire
Oct 20164212Highwire
Oct 2016081pmc
Nov 20165903Highwire
Nov 20160103pmc
Dec 20163410Highwire
Dec 20160145pmc
Jan 20173700Highwire
Jan 20170172pmc
Feb 20173301Highwire
Feb 20170233pmc
Mar 20172112Highwire
Mar 20170358pmc
Apr 20171500Highwire
Apr 201732726pmc
May 20172501Highwire
May 201723332pmc
Jun 20172100Highwire
Jun 201702731pmc
Jul 20172301Highwire
Jul 201752729pmc
Aug 20172202Highwire
Aug 201762120pmc
Sep 2017800Highwire
Sep 201724345pmc
Oct 20171010Highwire
Oct 201723842pmc
Nov 20171201Highwire
Nov 201754242pmc
Dec 20171301Highwire
Jan 20181101Highwire
Feb 20181311Highwire
Mar 20181321Highwire
Apr 20182310Highwire
Apr 201845055pmc
May 20181411Highwire
Jun 2018900Highwire
Jun 201875260pmc
Jul 20181311Highwire
Aug 20181010Highwire
Aug 201806266pmc
Sep 20181622Highwire
Oct 20181700Highwire
Nov 20181910Highwire
Dec 20182410Highwire
Jan 20191121Highwire
Feb 20192022Highwire
Mar 20192231Highwire
Apr 20192000Highwire
May 20191412Highwire
Jun 20191700Highwire
Jul 20191000Highwire
Aug 2019500Highwire
Sep 20191400Highwire
Oct 20191600Highwire
Nov 20192922Highwire
Dec 20192200Highwire
Jan 20202801Highwire
Feb 20201900Highwire
Mar 20201111Highwire
Apr 2020710Highwire
May 20201800Highwire
Jun 2020500Highwire
Jul 20201300Highwire
Aug 20201900Highwire
Sep 20202010Highwire
Oct 20202000Highwire
Nov 20201500Highwire
Dec 20202800Highwire
Jan 20211300Highwire
Feb 20211800Highwire
Mar 20211611Highwire
Apr 20211100Highwire
May 20212210Highwire
Jun 20211600Highwire
Jul 20211600Highwire
Aug 20213900Highwire
Sep 20211400Highwire
Oct 20212810Highwire
Nov 20211000Highwire
Dec 20212000Highwire
Jan 2022701Highwire
Feb 20221600Highwire
Mar 20221300Highwire
Apr 20221501Highwire

The Nerve!: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me